Gene Query: YARS2

Dataset Description Geneva Score
Adaptation of a RAS pathway activation signature from FF to FFPE tissues in colorectal cancer (FFPE RNA-Seq II) 102.09
The lung-enriched p53 mutants V157F and R158L/P regulate a novel transcriptome in lung cancer 30.6
Targeted reactivation of FMR1 transcription in FXS embryonic stem cells 15.31
Candidate genes and pathways downstream of PAX8 involved in ovarian high-grade serous carcinoma 11.19
A global identification of PUM1 and PUM2 mRNA targets and their protein cofactors in human seminoma TCam-2 cells 9.89
snRNAs as regulators of alternative splicing 8.98
Brain organoids reproducibly generate the cellular diversity of the human cerebral cortex 8.51
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator [RNA-seq] 8.14
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator 8.14
Uridylation by TUT4 and TUT7 marks mRNA for degradation 7.96
Effect of from Human Umbilical Vein Endothelial Cells 7.7
Model systems of DUX4 expression recapitulate the transcriptional profile of FSHD cells 7.38
Gene expression and 4sUDRB-seq for NF90/NF110 of human scramble and KD HeLa cells. 7.34
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [Nalm-6] 6.89
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma 6.79
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma (RNA-Seq) 6.79
Global transcriptional changes in the JJN3 myeloma cell line that occur as a result of treatment with 2 pyrrolobenzodiazepine (PBD) monomers 6.6
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer (BRD4_JQ1_RNA-seq) 6.44
The SPOP-containing Complex Functions as an E3 Ligase for SETD2 to Regulate Gene-Specific H3K36me3-Coupled Alternative Splicing 6.29
Regulation of protein translation during mitosis 6.22
Isolation and Transcriptome Analyses of Human Erythroid Progenitors: BFU-E and CFU-E 6.18
β-catenin/Tcf7l2 dependent transcriptional regulation of GLUT1 gene expression by Zic family proteins in colon cancer 6.12
Identification of mRNAs with reduced ribosomal loading upon knock-down of translation factor DAP5 from hESCs. 5.95
Reducing the structure bias of RNA-Seq reveals a large number of non-annotated non-coding RNA 5.89
CRISPR adenine and cytosine base editors with reduced RNA off-target activities 5.87
CRISPR adenine and cytosine base editors with reduced RNA off-target activities [CBE] 5.87
Cajal bodies are linked to genome conformation 5.85
Cajal bodies are linked to genome conformation [RNA-Seq] 5.85
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma [RNA-seq] 5.64
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma 5.64
RNA-seq analysis of control and CDK12-depleted ovarian cancer cells 5.57
DHX15 regulates CMTR1-dependent gene expression and cell proliferation 5.52
The cohesin complex prevents Myc-induced replication stress 5.5
A transcriptome-wide divergence in protein translation scales with LIN28B expression 5.41
Comparative whole-transcriptomic analysis between normal and AKAP-Lbc-depleted human embryonic stem cells 5.38
Effects of NSUN2 deficiency on the mRNA 5-methylcytosine modification and gene expression profile in HEK293 cells (RNA-Seq) 5.18
R430: A potent inbibitor of DNA and RNA viruses 5.16
Human Long Intergenic Noncoding RNA Linc-ADAL Knockdown in Mature Adipocytes using Lentiviral ShRNA 5.11
UBR7 is a novel E3 ubiquitin ligase for H2BK120 and acts as a tumor-suppressor in breast cancer 5.03
UBR7 is a novel E3 ubiquitin ligase for H2BK120 and acts as a tumor-suppressor in breast cancer [RNA-Seq] 5.03
Vitamin d receptor-mediated stromal reprogramming suppresses pancreatitis and enhances pancreatic cancer therapy 4.99
Global Promotion of Alternative Internal Exon Usage by mRNA 3' End Formation Factors 4.79
Global Regulation of Alternative Internal Exon Usage by mRNA 3' End Formation Factors [RNA-Seq] 4.79
Quantitative Analysis of PPARD Transcriptomes in Colon Cancer Cells by Next Generation Sequencing (NGS) 4.73
Uridylation by TUT4 and TUT7 marks mRNA for degradation [RNA-Seq] 4.67
Species-specific maturation profiles of human, chimpanzee and bonobo neural cells 4.65
RNA-seq data from human SGBS adipocytes differentiated with marine oxohexadecenoic acids 4.63
Generating Patterned Kidney Organoids for Studying Development and Diseases 4.62
RNA-seq analysis of control and Myc-induced U2OS cells 4.58
RBM25 is a global splicing factor promoting inclusion of alternatively spliced exons 4.55
DUX4-induced dsRNA and MYC mRNA Stabilization Activate Apoptotic Pathways in Human Cell Models of Facioscapulohumeral Dystrophy 4.55
Bromodomain protein BRD4 is a transcriptional repressor of autophagy and lysosomal function 4.53
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung [RNA-seq] 4.47
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung 4.47
Biochemical fractionation of HEK293 nuclei and RNA-seq of chromatin-associated and soluble-nuclear RNA 4.45
Transciptome profiling of NoDice and RNaseIII null cells prior to and after polyIC treatment 4.37
Transcriptomic analysis of T84 colon carcinoma cell line treated with trametinib, JQ1 or their combination 4.34
TCF21 and Aryl-hydrocarbon receptor gene cooperate to activate a pro-atherosclerotic gene expression program 4.26
Effect of drugs on transcriptomic profiles 4.22
Image based identification and targeting of cancer stem cells in pancreatic adenocarcinoma (PDAC) 4.2
Tumor suppressor SMARCB1 suppresses super-enhancers to govern hESC lineage determination 4.16
SNHG15 is a bifunctional MYC-regulated noncoding locus encoding a lncRNA that promotes cell proliferation, invasion and drug resistance in colorectal cancer by interacting with AIF 4.15
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq rescue_SS] 4.14
N6-methyladenosine Recruits HNRNPG for Alternative Splicing Regulation 4.09
Human Adult Sorted Live Cell Erythroblasts transduced with Sigma shRNA Clone TRCN0000005418 targeting RIOK3 with puromycin selection RNAseq 4.09
Genome-wide transcriptome analysis of NIPBL iPSC and commited cardiomyoctes 4.07
Seletive inhibition of CDK9 in DLBCL cell lines 4.06
Transcriptome analysis of dominant-negative Brd4 mutants identifies Brd4-specific target genes of BET inhibitor JQ1 4.06
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia 4.04
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia [RNA-seq] 4.04
Poly(A)-ClickSeq resolves CF25-mediated alternative poly-adenylation, HeLa 3.94
N6-methyladenine DNA Modification in Glioblastoma [RNA-seq] 3.93
N6-methyladenine DNA Modification in Glioblastoma 3.93
LNCaP treated with iBET 3.9
mRNA sequencing identifies differential gene expresssion profiles between ASCC3 knock-down cells and control cells 3.89
Expression data from A2780 cells treated with DMSO, Olaparib(Ola), Palbociclib(PD), and their combination (Ola/PD) 3.86
GREB1 amplifies androgen receptor output in prostate cancer and contributes to antiandrogen resistance 3.86
Transcriptome landscape of HeLa response upon triamcinolone acetonide 3.84
Ribo_seq (aka ribosome profiling) analysis of control and Myc-induced U2OS cells 3.81
RG/RGG boxes are common binding motifs in RNA-G-quadruplex-interacting proteins 3.77
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations [RNA-Seq] 3.76
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations 3.76
Deletion of DXZ4 on the human inactive X chromosome eliminates superdomains and impairs gene silencing 3.72
Differentially expressed genes post knock down of lincDUSP26 3.71
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures 3.66
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures [RNA-Seq] 3.66
Transcriptome analysis of genetically matched human induced pluripotent stem cells disomic or trisomic for chromosome 21 3.66
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation [RNA-Seq] 3.59
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation 3.59
The SUMO Pathway as a Therapeutic Option in Pancreatic Cancer 3.57
24hr CA treatment vs. DMSO in HCT116 cells (from 'Identification of CDK8 and CDK19 substrates in human cells using cortistatin A and quantitative phosphoproteomics') 3.57
Integrator complex regulates NELF-mediated RNA Polymerase II pause/release and processivity at coding genes. 3.48
Integrator complex regulates NELF-mediated RNA Polymerase II pause/release and processivity at coding genes [RNA-seq] 3.48
Transcriptome-wide identification of splicing defects upon XAB2 knockdown 3.48
Transcriptomic analysis of senescent cells upon PTBP1 knockdown and EXOC7 knockdown 3.46
Discovering the anti-cancer potential of non-oncology drugs by systematic PRISM profiling 3.45
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq SS] 3.44
Transcriptome splicing analysis in K562 cells expressing rare and private spliceosomal mutations 3.41
Oncogenic MYC induces a dependency on the spliceosome in human cancer 3.41
Transcriptomics analysis of gene expression in multiple human and mouse cells and tissues 3.37
3.35
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype [RNA-Seq] 3.35
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype 3.35
A role for p53 in the adaptation to glutamine starvation through the expression of Slc1a3 3.35
The dynamics of cellular response to therapeutic perturbation using multiplexed quantification of the proteome and transcriptome at single-cell resolution 3.3
Gene expression profile of HGC27 and LMSU gastric cancer cell p53 KO and KD 3.3
Gene expression changes caused by KRAS in MCF-10A 3.29
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (ChIP-seq & RNA-seq datasets) 3.28
The landscape of alternative splicing in aggressive prostate cancers 3.26
The stress granule transcriptome reveals principles of mRNA accumulation in stress granules. 3.26
Conserved roles for murine mDUX and human DUX4 in activating cleavage stage genes and MERVL/HERVL retrotransposons [RNA-Seq] 3.26
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation [cPDS-RNA-seq] 3.25
Biosynthesis of histone messenger RNA employs a specific 3' end endonuclease 3.24
Melanoma therapeutic strategies that select against resistance by exploiting MYC-driven evolutionary convergence 3.23
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development [set 1] 3.18
High-Throughput Kinetic Analysis of Fractional Killing 3.17
Transcriptome analysis of SKI knock-out in HL60 cells 3.17
Combined cistrome and transcriptome analysis of SKI in AML cells identifies SKI as a co-repressor for RUNX1 3.17
Transcription-dependent control of stem cell self-renewal and differentiation by the splicing factor U2AF1 3.12
Analysis of active enhancers and direct androgen receptor target genes in VCaP prostate cancer cells 3.05
SLIGRL-induced gene expression changes in NHEK cells 3.04
Therapeutic targeting of KDM1A/LSD1 in Ewing sarcoma engages the ER-stress response II 3.04
RNAseq of ribosomal fractionation to assess the effect of CBFB on translation regulation 3.0
The ZZ-type zinc finger of ZZZ3 modulates the ATAC complex-mediated histone acetylation and gene activation 2.99
Genomic expression analysis of K562 cells expressing shRNA targeting lncRNA-IIRX and control cells 2.97
Expression profile of LNCaP/AR cells with or without HNF4G expression grown for long term in charcoal stripped-serum (CSS) media 2.96
Activation of HOTTIP lncRNA perturbs HSC function leading to AML like disease 2.95
RNA-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 2.93
RNA-sequencing and MeDIP-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 2.93
Alu RNA modulates the expression of cell cycle genes in human fibroblasts 2.88
Next Generation Sequencing Facilitates Quantitative Analysis of HIV-1 Latency in Central Memory T Cells 2.86
Reprogramming postnatal human epidermal keratinocytes toward functional neural crest fates 2.86
RNA-seq data corresponding to: AZD4573 is a highly selective CDK9 inhibitor that suppresses Mcl-1 and induces apoptosis in hematological cancer cells 2.84
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues 2.84
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues (sequencing) 2.84
FBXW7 modulates stress response by post-translational modification of HSF1 2.84
Transriptional profiling upon heat shock and recovery in cells deficient for FBXW7 and their wild type counterpart. 2.84
CDK4/6 inhibitor resistance in prostate cancer 2.84
‘Naïve’ ESRRB+ iPSCs with the capacity for rapid neural differentiation 2.83
Human embryonic stem cell, chimpanzee induced pluripotent stem cell, orangutan induced pluripotent stem cell, rhesus embryonic stem cell, and their derived cortical organoid RNA-seq 2.83
TCF7L1 knockdown in pancreatic cancer 2.82
Next-generation sequencing analysis of transcriptom in gemcitabine resistant pancreatic cancer cells 2.8
RNA-Seq to assess the transcriptional effects of G quadruplex stabilization by the G4 ligand PhenDC3 in HT-1080 cells 2.77
MOF acetyl transferase regulates transcription and respiration in mitochondria 2.72
Chemotherapeutic drugs inhibiting Topoisomerase 1 activity inhibit TNF-induced inflammatory gene expression 2.7
HeLa transcriptome induction by IFN gamma and indoleamine 2,3-dioxygenase (IDO) 2.69
ICE1 promotes the link between splicing and nonsense-mediated mRNA decay 2.68
RNA-seq of Single-Cell Genotyping of Transcriptomes 2.68
Single-Cell Genotyping of Transcriptomes 2.68
RNAseq of HEK293 cells after Chtop knockdown 2.66
Co-transcriptional loading of RNA export factors shapes the human transcriptome 2.66
EIF1AX-A113 splice and RAS mutations cooperate to drive thyroid tumorigenesis through ATF4 and c-MYC 2.66
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes 2.66
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes [RNA-Seq] 2.66
Transcriptomic analysis of trametinib-resistant HCT116 colorectal carcinoma cells compared to the parental control cells 2.65
Characterization of human CDK12 and CDK13 in the regulation of RNA processing 2.64
Cleavage Factor Im as a key regulator of 3’ UTR length 2.63
pSILAC mass spectrometry reveals ZFP91 as novel IMiD dependent substrate of the CRL4CRBN ligase 2.63
Genome-wide maps in MCF-7 cells with six2 or CYP4Z1 3'UTR or CYP4Z2P 3'UTR overexpression or not 2.61
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of human mesenchymal stem cells differentiation from human embryonic stem cells and adult bone marrow mesenchymal stem cells 2.6
Perlman syndrome nuclease DIS3L2 controls cytoplasmic non-coding RNAs and provides surveillance pathway for maturing snRNAs 2.6
Stem cell and neurogenic gene-expression profiles link prostate basal cells to aggressive prostate cancer 2.59
Next generation sequencing analysis of transcriptomes at different timepoints after chlorprothixene treatment in NB4 and Kasumi-1 cells 2.56
Neurotrophic Tyrosine Kinase Receptor 1 is Epigenetically Regulated by IL-13 and Contributes to Allergic Inflammation 2.56
SNHG5 siRNA knock down in HCT116 cells 2.55
Circular RNAs are down-regulated in KRAS mutant colon cancer cells and can be transferred to exosomes 2.55
Interactions of aCPs with Cytosine-rich Polypyrimidine Tracts Enhance Splicing of Cassette Exons 2.55
Next Generation Sequencing Facilitates Quantitative Analysis of transcriptomes of human cord blood CD34+ cells treated with HDAC5 inhibitor 2.53
IGF2BP3 controls cancer cell invasiveness by modulation RISC function 2.53
Widespread N6-methyladenosine-dependent RNA Structural Switches Regulate RNA-Protein Interactions 2.52
Transcriptome analysis upon C6orf203 silencing 2.51
mRNA expression profile of A549 cells and MSR-A549 cells with or without JQ1 treatment 2.5
A549 cells and MSR-A549 cells 2.5
Retinoic Acid Induced Transcriptional Repressor HIC1 is Required for Suppressive Function of Human Induced Regulatory T cells [RNA-Seq 1] 2.48
Spatially Constrained Tandem Bromodomain Inhibition Bolsters Sustained Repression of BRD4 Transcriptional Activity for TNBC Cell Growth 2.47
Expression profiling by high throughput sequencing of tumors derived from human prostate epithelial cells transformed with the oncogenes N-Myc and myrAKT1. 2.46
Parkinson’s Disease Genetic Risk in a Midbrain Neuronal Cell Line 2.46
Transcriptional response to the HSP70 inhibitor MAL3-101 in parental rhabdomyosarcoma cells and isogenic acquired-resistance lines. 2.45
Histone deacetylase inhibition enhances antimicrobial peptide but not inflammatory cytokine expression upon bacterial challenge 2.44
mRNA profiles of JMJD3 overexpression- and JMJD3 knockout- HL-60 cells 2.43
ETV7 and interferon response 2.41
Impact of ETV7 activity on interferon-stimulated gene expression in 293T cells treated with interferon alpha 2.41
The regulartory role of ZCCHC24 in splicing machinery 2.41
A high-throughput screening strategy identifies regulators of alternative splicing via interaction with RNA G-quadruplexes 2.41
Global analysis of alternative splicing regulated by RBM10 2.4
Novel Non-catalytic Substrate-selective p38α-specific MAPK Inhibitors with Endothelial-Stabilizing and Anti-inflammatory Activity 2.39
MicroRNA (miR)-211 loss promotes metabolic vulnerability and BRAF inhibitor sensitivity in melanoma 2.39
Hijacking of stress response machinery by oncogenes in acute leukaemia [RNA-seq] 2.39
Hijacking of stress response machinery by oncogenes in acute leukaemia 2.39
Recruiting Endogenous ADARs with Antisense Oligonucleotides to Reprogram the Transcriptome 2.38
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice 2.38
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice [HCT116_RNA-seq] 2.38
PRDM1 inhibits proliferation of human colon cancer organoids 2.37
A Unique Epigenomic Landscape Defines Human Erythropoiesis (RNA-seq) 2.35
A Unique Epigenomic Landscape Defines Human Erythropoiesis 2.35
High Resolution Mapping of RNA Polymerases Identifies Mechanisms of Sensitivity and Resistance to BET Inhibitors in t(8;21) AML 2.35
RNA sequencing for PDX1, NGN3 and MAFA transduced iPSCs cell 2.35
Simultaneous detection and relative quantification of coding and non-coding RNA using a single sequencing reaction 2.35
STVI-120 Induction of differentiation in human epidermal stem cells followed by differential splicing analysis 2.33
Modeling the MYC-driven normal-to-tumour switch in breast cancer. 2.31
RNA-seq of RKO cells with cTAZ KO or putback 2.3
Adipocyte-derived lipids mediate melanoma progression via FATP proteins 2.29
Transcriptomic analysis of LSD1 2.28
Silencing p300 in MCF7 cells to study expression and alternative splicing 2.28
RNA-seq of YB5 and MCF7 treated with different doses of decitabine 2.28
RNA-seq of synchronized S phase or G2 phase cells treated with an ATR inhibitor 2.28
GRO-seq from HCT116, MCF7 and SJSA cell lines treated with DMSO and Nutlin 2.27
Identification of a core p53 transcriptional program with highly fractionated tumor suppressive activity 2.27
UBL5 is essential for pre-mRNA splicing and sister chromatid cohesion in human cells 2.26
UPF1/SMG7-dependent MicroRNA-mediated Gene Regulation 2.26
Small-molecule-based Human Genome G4 Profiling Reveals Potential Gene Regulation Activity 2.25
RNA-seq analysis of BAP1-depleted uveal melanoma cells 2.24
Nascent RNA Sequencing after NMYC activation in SH-EP MYCNER cells 2.23
Transcriptional profile of CAOV2 primary and CAOV2 recurrent cells 2.2
Reversible LSD1 Inhibition with HCI-2509 induces the p53 gene expression signature in high-risk neuroblastoma cells 2.2
Identification of Resistance Genes to BRAF Inhibitor in Melanoma by piggyBac Transposon Activation Mutagenesis Screen 2.16
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) 2.15
Acriflavine inhibits the epithelial-to-mesenchymal transition in vitro in liver and pancreatic cancer cells (part of study on HepG2) 2.15
The Polycomb protein BMI1 induces an invasive gene expression signature in melanoma that promotes metastasis and chemoresistance. 2.15
Isolation and Functional Interrogation of Adult Human Prostate Epithelial Stem Cells at Single Cell Resolution 2.15
Divergent effects of eRF3 and Upf1 on the expression of uORF carrying mRNAs and ribosome protein genes 2.14
C9orf72 Intermediate Repeats are Associated with Corticobasal Degeneration, Increased C9orf72 Expression and Disruption of Autophagy 2.13
Profiling of protrusion-enriched RNAs from human breast cancer cell line MDA-MB-231 2.13
Genome-wide discovery of human splicing branchpoints [RNAse] 2.13
TGF-b-activated LncRNA LINC00115 is a critical regulator for glioma stem-like cell tumorigenicity 2.13
Transcriptome analysis of H9 hESC derived cerebral organoids 2.12
Rorc disruption in human FG pancreatic cancer cells 2.12
Pseudotime Ordering of Single Human Beta-Cells Reveals States of Insulin Production and Unfolded Protein Response 2.12
Sequencing Universal Human Reference RNA by Smart-seq and early barcoding library preparation methods 2.11
Modelling and rescuing neurodevelopmental defect of Down syndrome using induced pluripotent stem cells from monozygotic twins discordant for trisomy 21 2.09
Modelling and rescuing neurodevelopmental defect of Down syndrome using induced pluripotent stem cells from monozygotic twins discordant for trisomy 21 [RNA-seq] 2.09
scRNASeq analysis of cycling cardiomyocytes 2.07
Wnt addiction of genetically defined cancers reversed by PORCN inhibition 2.07
CpG dinucleotides introduced into gag can inhibit HIV-1 gene expression by modulating pre-mRNA splicing 2.06
RNA-seq of cancer cell lines treated with T-025 2.06
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [K562] 2.05
HOXC6 affects the malignant phenotype of esophageal squamous cell carcinoma cells 2.04
RNA-seq analysis of FET cells treated with RSPO1 or TGFβ1 2.03
An improved method for circular RNA purification that efficiently removes linear RNAs containing G-quadruplexes or structured 3’ ends 2.03
TRIM28 interacts with EZH2 and SWI/SNF to activate genes that promote mammosphere formation 2.03
Genome wide transcriptome analysis of palbociclib or GSK3326595 treated A375 cells [Palbociclib_GSK_RNASeq] 2.0
Transcriptome profiling of 5 human adenocarcinoma cell lines 2.0
AUF-1 affected genes in human skin cells 2.0
The effect of insulin on mRNA transcription of human pluripotent stem cells 1.99
Oncolytic reactivation of KSHV as a therapeutic approach for primary effusion lymphoma: RNA-sequencing of PEL cell lines during KSHV reactivation 1.98
Characterisation of HIF-dependent alternative isoforms in pancreatic cancer 1.98
RUNX2/CBFB modulates the response to MEK inhibitors through activation of receptor tyrosine kinases in KRAS mutant colorectal cancer 1.98
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq Cell lines] 1.96
Splicing towards noncoding isoforms in colorectal carcinoma is associated with tumor hypoxia and the DNA damage response 1.95
Role for citron kinase in prostate cancer growth 1.94
CD95L derived si- and shRNAs and the CD95L mRNA kill cancer cells through an RNAi mechanism by targeting survival genes [siL3.RNAseq.lg] 1.94
Maintaining iron homeostasis is the key role of lysosomal acidity for cell proliferation 1.94
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation 1.93
Selective expression of long non-coding RNAs in a breast cancer cell progression model 1.92
A CLK3-HMGA2 alternative splicing axis impacts human hematopoietic stem cell molecular identity throughout development [BM low-input mRNA-seq] 1.92
Distinct regulation of alternative polyadenylation and gene expression by nuclear poly(A) polymerases 1.87
SEUSS: A scalable screening platform to assess transcriptomic and fitness effects of transcription factor overexpression 1.87
Identification of HOXB13 target genes responsive to BET inhibitors 1.86
Comparison of expression profiles of APP-depleted prostate cancer cells (LNCaP) 1.86
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer 1.85
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer (RNA-seq) 1.85
Tafazzin Regulates Cell State by Modulating Phosphatidylethanolamine and Phosphatidylserine levels 1.84
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells 1.83
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells (RNA-Seq) 1.83
The splicing factor RBM25 controls MYC activity in Acute Myeloid Leukemia 1.82
Multi-omic measurements of heterogeneity in HeLa cells across laboratories 1.81
Analysis of chromosomal aberrations and recombination by allelic bias in RNA-Seq 1.78
Tracing Enhancer Networks using Epigenetic Traits (TENET) 1.77
RNA-seq of YB5 cells treated with Proscillaridin A 1.77
Knockout human reveal an essential role for Paternally Expressed 10 (PEG10) in JEG3 cell line development 1.77
U2AF1 mutations alter splice site recognition in hematological malignancies 1.77
Sequencing of freshly produced RNA following exposure of cells to DNA damage-inducing UV mimetic 4-hydroxyaminoquinolone (4-NQO) 1.77
PTBP1 excludes UPF1 to protect long 3'UTRs from nonsense-mediated mRNA decay 1.74
Next Generation Sequencing Facilitates Quantitative Analysis of miR-29b-1 and miR-29a targets in tamoxifen-sensitive and tamoxifen-resistant human breast cancer cells 1.73
Ribosome profiling of TGFb-treated cells indicates reduced leucine availability 1.72
Genomic location of PRMT6-dependent H3R2 methylation is decisive for the transcriptional outcome of associated genes 1.71
Transcriptome analysis of PRMT6 knock-out in NT2/D1 cells 1.71
SLAM-seq for K562 endogenous mRNA decay 1.7
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing 1.7
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing [RNA-Seq] 1.7
BRG1 governs Glucocorticoid Receptor interactions with chromatin and pioneer factors across the genome 1.69
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma [RNA-Seq] 1.69
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma 1.69
A novel P300 inhibitor reverses DUX4-mediated global histone H3 hyperacetylation, target gene expression and cell death 1.69
Cap-specific terminal N6-methylation of RNA by an RNA polymerase II-associated methyltransferase. 1.69
Differential mRNA expression upon 9p21 deletion in HEK TE single-cell derived clones 1.69
Loss of 9p21 regulatory hub promotes kidney cancer progression by upregulating HOXB13 1.69
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (pooled infection) 1.66
Identification of differential expressed genes of JQ1 or JQ1+Bortezomib in colorectal cancer cells 1.64
Hypoxic transcriptome of SQ20B human head and neck cancer cells 1.63
Genes significantly down or Up-regulated upon RNF219 knockdown. [RNA-Seq] 1.62
Network-based, cross-cohort discovery of transcriptional mechanisms presiding over maintenance of high-risk neuroblastoma subtype state 1.62
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation 1.62
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development 1.6
Wnt1 silences CC/CXC motif chemokine genes in dendritic cells and induces adaptive immune resistance in lung adenocarcinoma 1.59
1.54
Global Transcriptome Analyses of Mammalian Terminal Erythroid Differentiation 1.53
Global analysis of enhancer targets: Mosaic-seq 1.51
Characterisation of the myeloid differentiation process of human hematopoietic stem cells 1.51
Targeting Taxane-Platin Resistant Lung Cancers with JumonjiC Lysine Demethylase Inhibitors (RNA-Seq) 1.5
Targeting Taxane-Platin Resistant Lung Cancers with JumonjiC Lysine Demethylase Inhibitors 1.5
Mitotic stress is an integral part of the oncogene-induced senescence program that promotes multinucleation and cell cycle arrest 1.49
RNA-seq analysis of differentiating human erythroblasts 1.48
Transcriptome profiling of H1-iCas9 cells grown on laminin and on MEFs 1.47
CLIC5: a novel ETV6 target gene in childhood acute lymphoblastic leukemia 1.47
LIN28A modulates splicing and gene expression programs in breast cancer cells 1.47
LIN28A modulates splicing and gene expression programs in breast cancer cells [RNA-Seq] 1.47
U1 snRNP telescripting regulates size-function stratified human genome 1.43
Long non-coding RNA TYKRIL controls pericyte function and survival in the cardiovascular and central nervous system through regulation of p53 activity and PDGFRß expression 1.41
Activation of the p53 transcriptional program sensitizes cancer cells to Cdk7 inhibitors 1.37
SAM68 is required for regulation of Pumilio by the NORAD long noncoding RNA 1.36
Single-Cell RNA Sequencing Reveals Metallothionein Heterogeneity during hESC Differentiation to Definitive Endoderm [RNA-Seq] 1.35
Effect of PBK knockdown on C4-2 cell transcriptome 1.35
Total RNA profiles associated with DDX3 wild-type (WT) or R534H variant expression with or without sodium arsenite treatment [RNA-seq] 1.34
Profiles of ribosome-associated mRNAs regulated by expression of wild-type (WT) or R534H variant of DDX3 with or without Sodium Arsenite treatment 1.34
Direct Isolation and Characterization of Human Nephron Progenitors. 1.33
HMGA2 Promotes Long-Term Engraftment and Myelo-Erythroid Differentiation of Human Hematopoietic Stem and Progenitor Cells 1.33
DHX36 is the missing link to understand RNA G-quadruplex structures, mRNA stability, and translation [RNA-seq] 1.33
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (RNA-seq dataset) 1.32
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [NALM6 RNA-Seq] 1.32
To investigate the decay constants (half-lives) of transcript isoforms generated by alternative polyadenylation in proliferating and quiescent cells 1.32
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis 1.31
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis [RNA-seq] 1.31
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs (expression) 1.31
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs 1.31
RNA-sequencing of mRNAs from control and CAP-D3 deficient Salmonella infected HT-29 cells 1.31
Assessing the effect of SUPT4H1 RNAi on the transcription of a repeat-containing reporter construct 1.28
RNA-Seq in two Ewing sarcoma cell lines: A673 and SKNMC 1.27
Dynamics of Proteo-Transcriptomic Response to HIV-1 Infection 1.26
RNA-sequencing transcriptome profiling of normal human keratinocytes differentiation 1.25
Functional Importance of eRNAs for Estrogen-dependent Gene Transcriptional Activation 1.24
RNA-Seq analysis of Head and Neck Squamous cell carcinoma cell-lines 1.2
Translating transcriptome of cancer cells in situ in mesenchymal-rich tumor microenvironment 1.19
Lipid catabolism inhibition sensitizes prostate cancer cells to antiandrogen blockade 1.18
Effect of PRDM11 depletion in U2932 cells 1.18
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation [bulk] 1.17
Identification of altered developmental pathways in human juvenile HD iPSC with 71Q and 109Q using transcriptome profiling 1.16
Polysome profiling RNAseq of cells transfected with an oligonucleotide targeting the ES6S region of the 40S subunit 1.16
A20 regulates canonical wnt-signaling through an interaction with RIPK4 1.15
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 [HOM] 1.12
Small molecule inhibition of ERK dimerization prevents tumorigenesis by Ras-ERK pathway oncogenes 1.12
Investigation into human Tra2 protein-dependent splicing in MDA-MB-231 cells using iCLIP and RNA-seq 1.11
LEDGF and HDGF2, histone H3K36 methyl-binding proteins that assist RNA polymerase II transcription through nucleosomes 1.1
Identification of Differentially Expressed Splice Variants by the Proteogenomic Pipeline Splicify 1.1
The metabolome regulates the epigenetic landscape during naïve to primed human embryonic stem cell transition 1.1
Global transcriptional analysis and genome-wide analysis of chromatin state in extended pluripotent stem cells, primed pluripotent stem cells, and naïve pluripotent stem cells 1.09
Global transcriptional analysis of human extended pluripotent stem cells, human primed pluripotent stem cells, mouse extended pluripotent stem cells, and mouse embryonic stem cells by RNA-seq 1.09
RNA-seq analysis of the role of HBO1 (KAT7/MYST2) in the ovarian cancer cell line UWB1.289. 1.09
Fra-1 is a key driver of colon cancer metastasis and a Fra-1 classifier predicts disease-free survival 1.09
ADAR1-editing of cellular and measles virus-derived duplex RNA 1.08
ADAR1-editing in HeLa, p150-KO and ADAR1-KO transcriptomes 1.08
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription 1.08
A non-catalytic function of carbonic anhydrase IX contributes to the glycolytic phenotype and pH regulation in human breast cancer cells 1.08
A Non-Canonical Nuclear Activity Triggered by Small RNAs and Argonaute Proteins in Human Cells 1.08
p38 SAPK and SKIIP induced changes in alternative splicing patterns upon osmostress 1.05
RNA-Seq analysis of JIB-04 effects on global cellular transcription and HIV in 2D10 T cells 1.05
An Argonaute phosphorylation cycle promotes microRNA-mediated silencing [whole transcriptome RNA-seq] 1.05
Tyrosine-1 of RNAPII CTD controls global termination of gene transcription in mammals 1.04
KSDM1b Role in Ewing Sarcoma 1.04
Functional significance of the HIV-1 Tat signature amino acid residues 1.04
Targeting MYC dependency in ovarian cancer through inhibition of CDK7 and CDK12/13 1.02
RNA-seq analysis of control and ZC3H18-depleted ovarian cancer cells 1.02
Real-time observation of light-controlled transcription in living cells 1.0
RNA-seq of HEK293T cells overexpressing TET1-FL or TET1-ALT 0.99
Pseudouridylation of tRNA-derived fragments steers translation control in stem cells [Polysome-Seq] 0.98
A Druggable TCF4- and BRD4-dependent Transcriptional Network Sustains Malignancy in Blastic Plasmacytoid Dendritic Cell Neoplasm (RNA-Seq) 0.98
LncRNA NMR knockdown and overexpression in esophageal squamous cell carcinoma cell lines 0.97
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells 0.95
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells (RNA-seq) 0.95
SETDB1 compacts the inactive X chromosome in part through silencing an enhancer in the IL1RAPL1 gene 0.95
Host transcriptome analysis of Aspergillus fumigatus infection in Airway Epithelial Cells 0.95
Silencing SPIB in attached and floating state of H1703 lung cancer cells 0.94
MARS Seq data from human cortical organoids 0.92
RNA seq with AML (NB4) cells upon FTO inhibition 0.92
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer [RNA-seq] 0.9
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer 0.9
Comparative Analysis of Cas9 Activators Across Multiple Species 0.89
Non-transmissible measles virus vector with segmented RNA genome establishes different types of iPSCs from hematopoietic cells 0.89
Gene expression analysis upon mtDNA depletion [RNA-seq] 0.88
Gene expression analysis upon mtDNA depletion 0.88
Gene expression profile in breast cancer cells 0.88
Genome-wide profile of cJun and p27 and gene expression profile in breast cancer cells 0.88
Effects of Inhibition of CDK8/19 Mediator Kinase by Senexin B in HEK293 cells treated with or without TNF-alpha 0.86
An siRNA screen identifies CHD4 as a target for epigenetic therapy 0.86
Human muscle-derived CLEC14A-positive cells regenerate muscle independent of PAX7 0.83
Epigenomic conservation of transposable element silencing [RNA-seq] 0.82
Epigenomic conservation of transposable element silencing 0.82
Ribosome profiling upon inhibition of eIF4A 0.8
Identification of transcripts altered upon LIN-41 knockdown in human embryonic stem cells 0.78
Human Embryoid Body Transcriptomes Reveal Maturation Differences Influenced by Size and Formation in Custom Microarrays 0.77
RUVBL1/RUVBL2 ATPase Activity Drives PAQosome Maturation, DNA Replication and Radioresistance in Lung Cancer 0.76
CRISPR/Cas9 Screens Reveal Epstein-Barr virus Synthetic Lethal Targets 0.75
Gene expression profile of HGC27 gastric cancer cell p53 KO and KD 0.73
Knock-down of Ror1 in MDA-MB-231 cell line decreases cell invasiveness 0.73
RNA G-quadruplexes mark repressive upstream open reading frames in human mRNAs 0.72
Mediator kinase inhibition further activates super-enhancer-associated genes in AML 0.72
Effect in HCT116 cells of 3hr cortistatin A treatment on gene expression. 0.72
Osmostress induced changes of chromatin architecture and transcription in mammalian cells [RNA-Seq, HiC] 0.7
Osmostress induced changes of chromatin architecture and transcription in mammalian cells 0.7
Single-cell transcriptomics of human oocytes: environment-driven metabolic competition and compensatory mechanisms during oocyte maturation 0.69
RNA-Seq data of NCI-H82 cells expressing a Dox-On pRB (pTripZ RB1) grown in the presence or absence of DOX and then treated with vehicle or AZD2811. 0.68
Analysis of HPV16 E2 host gene expression using TERT immortalized keratinocytes (NOKs) cell lines and RNA-sequencing 0.68
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 2] 0.68
RNA-Seq of SLNCR1 over-expression in the melanoma cell line A375 0.66
Analysis of human ES cell differentiation establishes that the dominant isoforms of the lncRNAs RMST and FIRRE are circular 0.66
Myc activation coordinates gene transcription and protein translation responses 0.62
Disease modelling of core pre-mRNA splicing factor haploinsufficiency 0.59
HBEC-shp53-PCHD7 0.58
Transient stabilization, rather than inhibition of MYC amplifies extrinsic apoptosis and therapeutic responses in refractory B-cell lymphoma 0.57
A MYC/GCN2/eIF2alpha negative feedback loop limits protein synthesis to prevent MYC-dependent apoptosis in colorectal cancer 0.57
Folliculin regulates mTORC1/2 and WNT pathways in early human pluripotency 0.56
A pooled single-cell genetic screen identifies regulatory barriers in the continuum of the epithelial-to-mesenchymal transition 0.56
Structure and degradation of circular RNAs regulate PKR activation in innate immunity 0.55
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer 0.55
Hsa-miR-139-5p/HNRNPF axis modulates gene-transcripts balance in thyroid cancer cells 0.54
Spontaneous single-copy loss of TP53 in human embryonic stem cells markedly increases cell proliferation and survival [RNA-Seq] 0.52
Spontaneous single-copy loss of TP53 in human embryonic stem cells markedly increases cell proliferation and survival 0.52
Universal alternative splicing of noncoding exons 0.51
Treatment of prostate cancer cells with S-adenosylmethionine leads to genomewide alterations of transcription profiles 0.51
Identification of novel recurrent ETV6-IGH fusions in primary central nervous system lymphoma using high throughput RNA sequencing 0.5
Analysis of gene expression in SKOV3 ovarian cancer cells after knockdown of the long non-coding RNA DNM3OS 0.5
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process (RNA-seq) 0.49
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process 0.49
Single-cell Transcriptomics reveals multi-step adaptations to endocrine therapy 0.49
Genomic deletion of malic enzyme 2 confers collateral lethality in pancreas cancer 0.49
Next generation sequencing of the transcriptome in MCF-7 cells with/without SRA knockdown 0.48
Inactivation of CFTR by CRISPR/Cas9 alters transcriptional regulation of inflammatory pathways and other networks 0.45
A novel target of EZH1/2 for treatment of mantle cell lymphoma 0.44
Efficient and precise editing of endogenous transcripts with SNAP-tagged ADARs 0.43
ZEB1 insufficiency causes corneal endothelial cell state transition and altered cellular processing 0.41
p53 activity results in DNA replication fork processivity 0.41
RNA sequencing of isogenic BRCA2 haploinsufficient vs. wild-type T-ALL cells 0.4
Transcriptome-wide analysis links the short-term expression of the b isoforms of T-cell intracellular antigens to protective proteostasis-mediated survival and quiescence 0.4
Effect of PDZ domain binding Kinase inhibition using TOPK-32 (called PBKi) on C4-2 cell transcriptome 0.39
Transcriptional changes after overexpression of proliferation drivers in human mammary epithelial cells. 0.39
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and SMAD4 Y95 Mutation Transcriptomes 0.38
RNA-seq, ChIP-seq and single cell RNA-seq of human skin Langerhans cells 0.36
TALEN-based knockout of mir-141 and mir-200c in SK-BR-3 cells 0.35
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma 0.34
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma [RNA-seq] 0.34
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition [RNA-Seq] 0.34
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition. 0.34
Global transcriptome analysis in the MYCN-amplified neuroblastoma cell line IMR5-75 upon inducible MYCN-knockdown 0.33
MYC interacts with the G9a histone methyltransferase to drive transcriptional repression and tumorigenesis 0.32
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells 0.3
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells [RNA-Seq] 0.3
Tunable protein synthesis by transcript isoforms in human cells (Transcript Isoforms in Polysomes sequencing: TrIP-seq) 0.3
Genome-wide maps of WT and over-expressing CenH3/CENP-A in Human HeLa S3 cells 0.28
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo 0.27
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo [RNA-Seq] 0.27
Browning of human adipocytes requires KLF11 and reprogramming of PPARγ super-enhancers 0.26
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription [RNA-Seq2] 0.26
The long non-coding RNA MALAT1 contributes to the pathogenesis of multiple sclerosis through alternative splicing and backsplicing regulation 0.26
ARS2 is a general suppressor of pervasive transcription [RNAseq] 0.25
Genome-wide analysis of the Integrator complex 0.25
Genome-wide analysis of the Integrator complex (HTS) 0.25
Identification and mitigation of pervasive off-target activity in CRISPR-Cas9 screens for essential non-coding elements 0.25
Transcriptome analysis of immature and matured human oocytes from patients of young and advanced maternal age 0.23
siRNA-mediated knockdown 0.23
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (scRNA-Seq) 0.23
KAP1 regulates ERVs in differentiated human cells and contributes to innate immune control 0.23
Whole transcriptome profile of citrulline-specific B cells from patients with rheumatoid arthritis 0.22
Xeno-free and Chemically Defined Human System for Culturing Human Epidermal Keratinocytes 0.22
Gene expression changes due to PARP knockdown in human cells 0.22
Ribosomal protein RPL26 is the principal target of UFMylation 0.21
m6A-dependent regulation of messenger RNA stability 0.21
Genome-wide mapping of TEL-AML1 targets in acute leukemia 0.2
Sorted MDMs with RFP+GFP+ or RFP+GFP- Mtb 0.2
Folate modulation induces chromosomal instability and higher proliferation of immortalized human keratinocytes 0.2
Next Generation Sequencing Facilitates Quantitative Analysis of UVB(20mJ/cm2 and 40mJ/cm2) exposed and untreated HaCaT keratinocytes Transcriptomes 0.19
Global transcriptome analysis of WT versus HEB-/- hESCs 0.19
Human Cactin interacts with DHX8 and SRRM2 to assure efficient pre-mRNA splicing and sister chromatid cohesion. 0.19
Dnmt3a and Dnmt3b associate with enhancers to regulate human epidermal stem cell homeostasis 0.18
Analysis of transcriptional differences after IFN-beta (IFN-b) or IFN-lambda (IFN-l) treated human mid-gestation chorionic villus explants 0.18
Transcriptional analysis of ZIKV-infected Ifnar-/- and Ifnar+/- placentas and IFN-beta (IFN-b) or IFN-lambda (IFN-l) treated human mid-gestation chorionic villus explants 0.18
Recapitulating and Deciphering Tumor-stroma Microenvironment by Using a “LEGO” like 3D printed microfluidic device 0.15
GLIS3 Transcriptionally Activates WNT Genes to Promote Differentiation of Human Embryonic Stem Cells to Posterior Neural Progenitors 0.15
Transcriptomics analysis of gene expression in normal and YTHDC1, SRSF1, SRSF3, SRSF7, SRSF9 or SRSF10 deficient human HeLa cells 0.15
rG4-seq reveals widespread formation of G-quadruplex structures in the human transcriptome 0.12
Chromatin remodeling mediated by ARID1A is indispensable for normal hematopoiesis in mice (human RNA-Seq) 0.11
Transcription factors and stress response gene alterations in human keratinocytes following Solar Simulated Ultra Violet Radiation 0.11
MicroRNA-28 replacement for non-Hodgkin lymphoma therapy 0.1
Stapled peptide inhibitors of RAB25 target context-specific phenotypes in cancer 0.09
The MEF2B Regulatory Network 0.09
The MEF2B Regulatory Network - RNA-seq data 0.09
RNA-seq analysis of PRMT5-regulated genes in irradiated/non-irradiated LNCaP cells 0.09
RNA sequencing analysis of selumetinib-resistant CRC cells lines 0.08
The WNT target SP5 negatively regulates WNT transcriptional programs in human pluripotent stem cells 0.07
Transcriptional study of ARN8 cells treated with novel DHODH inhibitors 0.06
Transcriptome-wide modulation of splicing by the exon junction complex 0.06
Function and hormonal regulation of GATA3 in human first trimester placentation 0.04
RNA seq analysis of human Fetal and adult derived Enterospheres 0.04
Evaluating and comparing the Transcriptome of (human) Hek 293 based cells, expressing either CHD3 or CHD4 0.03
Hyperactive mTOR and MNK1 phosphorylation of eIF4E confer tamoxifen resistance and estrogen independence through selective mRNA translation reprogramming 0.03
The effect of doxycycline-induced expression of host-cell-factor 2 (HCF-2) proteins on the global gene expression in HEK-293 cells 0.02
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates 0.02
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates [RNA-seq] 0.02
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (separate infection) 0.01
Targets mediated microRNA arm-imbalance promotes gastric cancer progression [lncRNA] 0.01
Human Treg IFNg/IL-10 subpopulations 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation